Oncology
Oncology
Advertisement
Jordana JampelHead and Neck Cancer | December 12, 2024
The researchers hypothesized that the prognostic value of diurnal cortisol aberrations will hold in HNC.
Read More
Jordana JampelBreast Cancer News | December 12, 2024
The positive predictive value for cancer was 15% higher for those enrolled.
Jordana JampelMelanoma | December 4, 2024
TPC2 and Rab7a interaction may be responsible for melanoma proliferation.
Jordana JampelBreast Cancer News | December 3, 2024
The most frequent changes detected were additional copies of chromosome 1q and losses of chromosomes 10q, 16q, and 22.
Jordana JampelGynecologic Cancer | November 26, 2024
Based on these results, a three-diode laser vaginal session enhances and favors the complete closure of VVFs.
Rob DillardMelanoma | November 21, 2024
Remote analysis of cancerous-looking skin growths yields the same level of accuracy as in-person analysis.
Jordana JampelBreast Cancer News | November 19, 2024
Twelve chemicals were associated with increased breast cancer risk.
Jordana JampelMelanoma | November 18, 2024
Seventy-two percent of tumor specimens contained histologically defined LAs.
Jordana JampelBreast Cancer News | November 18, 2024
Heterozygosity in BRCA1 genes is not enough to prevent tumor proliferation, according to researchers out of Harvard.
Jordana JampelGynecologic Cancer | November 13, 2024
Deep learning algorithms combined with MRI could have a major impact on diagnosing patients with high-risk disease.
Rob DillardBreast Cancer News | November 12, 2024
Thyroid and parathyroid dysfunction is common among women with breast cancer following radiotherapy.
Jordana JampelHead and Neck Cancer | November 11, 2024
Researchers aimed to find a marker to accurately predict the prognosis of HNSCC and to find novel immune targets.
Jordana JampelMelanoma | November 11, 2024
The analysis included the CheckMate trials that involved ICI treatment-naive unresected/metastatic melanoma.
Jordana JampelBreast Cancer News | November 11, 2024
A study aimed to assess TILs as predictors of response to neoadjuvant chemotherapy in locally advanced breast cancer.
Dr. John Fruehauf, EvolentMelanoma | November 7, 2024
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma. 
Jordana JampelGynecologic Cancer | November 6, 2024
A Mendelian randomized analysis was performed to determine the effects of anti-CD20 antibodies on endometrial cancer.
Jordana JampelBreast Cancer News | November 8, 2024
Researchers designed a interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer.
Jordana JampelHead and Neck Cancer | November 7, 2024
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Rob DillardBreast Cancer News | October 31, 2024
A novel method can assess which patients with TNBC could benefit from immunotherapy.
Jordana JampelBreast Cancer News | October 28, 2024
This could be a needed breakthrough for those predisposed to breast and ovarian cancer mutations.
Advertisement
Advertisement
Advertisement
Latest News

December 13, 2024